Dividend Growth Market Leaders
10.27k followers • 11 symbols Watchlist by The Motley Fool
Companies that not only tend to beat the market, but pay you as they do.
Curated by The Motley Fool
Dividend Aristocrats are the model of consistency. To be a part of the club, a company must be a member of the S&P 500 index and have increased its annual dividend payment for the last 25 years. Many associate the group with income investing and dividend growth, but Dividend Aristocrats have beaten the broader market in total returns, notching better results over one-,three-, five-, and 10-year periods. Within this group of quality companies, our analysts like 10 in particular for investors looking for steady stable income (and some growth too!).
How did we choose these stocks?Each of these stocks is not only a Dividend Aristocrat but also an active recommendation of a Motley Fool premium investing service as of 8/31/2016.
Who made these selections?The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.
How are these weighted?This watchlist consists of equally weighted stocks.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Dividend Growth Market Leaders | +0.85% | +1.48% | +23.44% | +14.86% |
| ^GSPC | +0.74% | +2.53% | +44.45% | +4451.18% |
11 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 168.5 | +0.76 | +0.45% | 4:00 pm GMT-4 | 5.32M | 7.53M | 443.73B |
| XOM | Exxon Mobil Corporation | 62.43 | +0.88 | +1.43% | 4:04 pm GMT-4 | 32.28M | 27.92M | 264.30B |
| KO | The Coca-Cola Company | 54.51 | -0.03 | -0.06% | 4:00 pm GMT-4 | 10.64M | 15.96M | 235.03B |
| MCD | McDonald's Corporation | 234.84 | -0.02 | -0.01% | 4:00 pm GMT-4 | 1.41M | 3.02M | 175.23B |
| MDT | Medtronic plc | 126.7 | -0.60 | -0.47% | 4:00 pm GMT-4 | 3.87M | 4.75M | 170.80B |
| SHW | The Sherwin-Williams Company | 287.23 | +1.84 | +0.64% | 4:00 pm GMT-4 | 888.14k | 1.48M | 76.39B |
| EMR | Emerson Electric Co. | 95.05 | +1.33 | +1.42% | 4:04 pm GMT-4 | 3.42M | 2.83M | 57.00B |
| AFL | Aflac Incorporated | 56.11 | -0.07 | -0.12% | 4:00 pm GMT-4 | 2.60M | 3.50M | 38.14B |
| CTAS | Cintas Corporation | 360.67 | +10.42 | +2.98% | 4:00 pm GMT-4 | 567.10k | 401.54k | 37.89B |
| MKC | McCormick & Company, Incorporated | 89.33 | -0.90 | -1.00% | 4:00 pm GMT-4 | 843.25k | 1.35M | 23.85B |
- Reuters
UPDATE 1-Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission
Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday. Those who would volunteer to take either of the two vaccines should however be allowed to do so, the commission added. Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.
- Reuters
Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission
Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday. Those who would volunteer to take either of the two vaccines should however be allowed to do so, the commission added. Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.
- Investing.com
Dollar Weakness; Payrolls Could Delay Fed Tapering
The dollar edged lower in early European trade Monday, continuing its weakness after falling to a two-month low on the back of Friday’s disappointing U.S. jobs report, which pointed to the ultra-low interest rate policy staying in place for some time. Friday’s U.S. employment report for April came in well below expectations, with nonfarm payrolls only rising by 266,000 during the month, after robust private payrolls data from the ADP and weekly initial claims numbers had lifted expectations to a one million-plus rise. Attention will now switch this week to inflation data, although the mantra from Fed policymakers that the increase is due to temporary factors will carry extra weight following the jobs data.
